Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 25.08.2025 1 Am J Cardiol 1 Am J Med 1 Am J Ophthalmol 5 Ann Intern Med 1 Atherosclerosis 1 Biochem Biophys Res Commun 2 BMC Ophthalmol 1 BMC Pediatr 3 BMJ 2 Br J Ophthalmol 1 Clin Med Insights Pediatr 7 Diabet Med 9 Diabetes 18 Diabetes Care 15 Diabetes Obes Metab 7 Diabetologia 1 Eur J Endocrinol 5 Invest Ophthalmol Vis Sci 5 J Clin Endocrinol Metab 2 J Clin Invest 5 J Diabetes Complications 1 Nature 1 Nutr Metab (Lond) 1 Ophthalmol Retina 1 Ophthalmology 6 PLoS One 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. GARDNER RK, Tale A, Wadhera RK
   Geographic Variation in Cardiometabolic and Lifestyle Risk Factors Across US States, 2011 to 2021.
   Am J Cardiol. 2025;251:46-53.
   PubMed         Abstract available
   
   

   
   Am J Med

2. KURAMOTO N, Hironaka J, Okada H, Hasegawa Y, et al
   A Meta-Analysis of Available Data of the Effects of Selected Whole and Powdered Fruits on Glycemia in Type 2 Diabetes.
   Am J Med. 2025 Aug 15:S0002-9343(25)00528-5. doi: 10.1016/j.amjmed.2025.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. HUSSAIN ZS, Shakarchi AF, Chauhan MZ, Jester DA, et al
   Is There a Safe Glycemic Threshold for Cataract Surgery?
   Am J Ophthalmol. 2025 May 3:S0002-9394(25)00221.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. RUIZ-CANELA M, Corella D, Martinez-Gonzalez MA, Babio N, et al
   Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes : A Secondary Analysis of a Randomized Controlled Trial.
   Ann Intern Med. 2025 Aug 26. doi: 10.7326/ANNALS-25-00388.
   PubMed         Abstract available
   
   
5. 
   Summary for Patients: Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes.
   Ann Intern Med. 2025 Aug 26. doi: 10.7326/ANNALS-25-00388.
   PubMed        
   
   
6. HERRING SJ, Tripicchio GL
   Reducing Diabetes Risk Through the Mediterranean Diet.
   Ann Intern Med. 2025 Aug 26. doi: 10.7326/ANNALS-25-02748.
   PubMed        
   
   
7. CENTOR RM, Kip K, Saeed A
   Web Exclusive. Annals On Call - Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes.
   Ann Intern Med. 2025;178:e2503594OC.
   PubMed        
   
   
8. LAU D, Senior P
   In insulin-treated T2D, automated insulin delivery reduced HbA(1c) without increasing hypoglycemic events vs. usual care at 13 wk.
   Ann Intern Med. 2025;178:JC95.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

9. KITAHARA S, Kataoka Y, Nicholls SJ, Funabashi S, et al
   Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.
   Atherosclerosis. 2025;409:120470.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

10. HONG Y, Kim J, Kim YG, Cha J, et al
    DA-9701 (Motilitone(R)) improves glucose homeostasis by protecting STZ-induced beta-cells death.
    Biochem Biophys Res Commun. 2025;778:152409.
    PubMed         Abstract available
    
    

    
    BMC Ophthalmol

11. LI K, Han Y, Zhang Y, Ma Q, et al
    Analysis of the correlation between corneal and meibomian gland morphology and glycated hemoglobin levels in type 2 diabetes patients.
    BMC Ophthalmol. 2025;25:480.
    PubMed         Abstract available
    
    
12. HAO Y, She X, Huang G, Chu X, et al
    Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.
    BMC Ophthalmol. 2025;25:460.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

13. HASSANI M, Mohammadi F, Khazaie S, Effat Panah M, et al
    Comparison of identity crisis in adolescents with cancer and diabetes, a cross-sectional study.
    BMC Pediatr. 2025;25:635.
    PubMed         Abstract available
    
    

    
    BMJ

14. BOWIE K
    Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance "shake-up".
    BMJ. 2025;390:r1777.
    PubMed        
    
    
15. KAR P
    Partha Kar: The Super Six diabetes care model offers lessons for shifting care into the community.
    BMJ. 2025;390:r1727.
    PubMed        
    
    
16. BOWIE K
    Type 1 diabetes: UK approves first drug for delaying onset.
    BMJ. 2025;390:r1762.
    PubMed        
    
    

    
    Br J Ophthalmol

17. JOSEPH S, Wang Y, Drinkwater JJ, Jan CL, et al
    Effectiveness of artificial intelligence-based diabetic retinopathy screening in primary care and endocrinology settings in Australia: a pragmatic trial.
    Br J Ophthalmol. 2025 Aug 22:bjo-2025-327447. doi: 10.1136/bjo-2025-327447.
    PubMed         Abstract available
    
    
18. LIU Z, Huang Y, Jin L, Pan C, et al
    Validation of a self-administered Home ETDRS visual acuity testing (H-ETDRS) for self-monitoring vision changes in retinal diseases.
    Br J Ophthalmol. 2025 May 10:bjo-2024-326283. doi: 10.1136/bjo-2024-326283.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Pediatr

19. SEBRO SF, Saliya SA, Ashine TM, Heliso AZ, et al
    Incidence and Predictors of Diabetic Keto-acidosis Among Children Under 15 Years At Central Ethiopia Public Hospital A Retrospective Cohort Study.
    Clin Med Insights Pediatr. 2025;19:11795565251349122.
    PubMed         Abstract available
    
    

    
    Diabet Med

20. KHAVERE S, Hadjiconstantinou M, Miksza J, Hagan J, et al
    Effectiveness of self-management interventions on Type 2 diabetes among young adults (18-45 years): A systematic review and meta-analysis.
    Diabet Med. 2025 Aug 21:e70127. doi: 10.1111/dme.70127.
    PubMed         Abstract available
    
    
21. DONVITO G, Maltecca C, Hofer SE, Meraner D, et al
    Quality of diabetes mellitus healthcare and metabolic control during transition from paediatric to adult care: A systematic review and meta-analysis.
    Diabet Med. 2025 Aug 20:e70125. doi: 10.1111/dme.70125.
    PubMed         Abstract available
    
    
22. TABESH M, Sacre JW, Mehta K, Chen L, et al
    Associations of glycaemia-related risk factors with dementia and cognitive decline in individuals with type 2 diabetes: A systematic review and meta-analysis.
    Diabet Med. 2025 Aug 19:e70123. doi: 10.1111/dme.70123.
    PubMed         Abstract available
    
    
23. HOLT RIG, Peyrot-Stuckey H, Bohning D, Taylor J, et al
    The Diabetes Attitudes Wishes and Needs (DAWN)-SMI study: A cross sectional comparison of the psychosocial impact of diabetes in adults with and without severe mental illness.
    Diabet Med. 2025 Aug 16:e70126. doi: 10.1111/dme.70126.
    PubMed         Abstract available
    
    
24. MULLER N, Kellner C, Schmidt S, Kuniss N, et al
    How do hypoglycaemias affect the everyday life of people with diabetes and are they able to treat them adequately?
    Diabet Med. 2025 Aug 16:e70121. doi: 10.1111/dme.70121.
    PubMed         Abstract available
    
    
25. DE ZOYSA N, Chadwick P, Ferguson C, Gianfrancesco C, et al
    Training DAFNEplus facilitators in novel behaviour change approaches: A template for training design and delivery.
    Diabet Med. 2025;42:e70078.
    PubMed         Abstract available
    
    
26. WANG R, Kyi M, Krishnamoorthi B, Connell A, et al
    Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility.
    Diabet Med. 2025;42:e70076.
    PubMed         Abstract available
    
    

    
    Diabetes

27. WEISS ME, Patel MJ, Watts BH, Parrales PE, et al
    Investigating Late-Stage Diabetic Retinopathy: A Long-term Analysis of Vascular Changes in the Streptozotocin-Induced Mouse Model.
    Diabetes. 2025 Aug 21:db250434. doi: 10.2337/db25-0434.
    PubMed         Abstract available
    
    
28. GILLESPIE KM
    Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.
    Diabetes. 2025;74:1466-1468.
    PubMed        
    
    
29. PAGE B
    Diabetes Spotlight: David J. Hodson, BVSc, PhD, FRCVS-Regulation of Insulin and Glucagon in Pancreatic Islet Biology.
    Diabetes. 2025;74:1443-1444.
    PubMed        
    
    
30. ASSAF J, Khurana I, Abou Zaki R, Tam CHT, et al
    DNA Methylation Biomarkers Predict Offspring Metabolic Risk From Mothers With Hyperglycemia in Pregnancy.
    Diabetes. 2025;74:1695-1707.
    PubMed         Abstract available
    
    
31. REYNOLDS KM, Sun Q, Zhang Y, Umans J, et al
    Diabetes Genetic Clusters and Clinical Outcomes in American Indians.
    Diabetes. 2025 Aug 18:db250322. doi: 10.2337/db25-0322.
    PubMed         Abstract available
    
    
32. ZHANG Y, Dai L, Wang M, Zhong X, et al
    Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIdelta Axis.
    Diabetes. 2025 Aug 15:db250077. doi: 10.2337/db25-0077.
    PubMed         Abstract available
    
    
33. ABDELGANI S, Khattab A, Adams JM, Al-Mulla F, et al
    Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial.
    Diabetes. 2025;74:1480-1488.
    PubMed         Abstract available
    
    
34. ZHOU M, Yang X, Ge X, Chen J, et al
    Reducing PTP1B in the Hippocampus Protects Against Cognitive Decline in Prediabetes.
    Diabetes. 2025;74:1499-1511.
    PubMed         Abstract available
    
    
35. OSIPOVICH AB, Dickerson MT, Cartailler JP, Shrestha S, et al
    Dynamic Ca2+-Dependent Transcription Links Metabolic Stress to Impaired beta-Cell Identity.
    Diabetes. 2025;74:1547-1561.
    PubMed         Abstract available
    
    

    
    Diabetes Care

36. TANABE H, Takiguchi Y, Tsutsumi R, Shiroma K, et al
    Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study.
    Diabetes Care. 2025 Aug 25:dc251067. doi: 10.2337/dc25-1067.
    PubMed         Abstract available
    
    
37. GRIFFIN KE, Snyder K, Javid AH, Hackstadt A, et al
    Response to Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-
    Diabetes Care. 2025;48:e113-e114.
    PubMed        
    
    
38. DIEGUEZ AC, Kuang A, Josefson JL, Scholtens DM, et al
    Response to Comment on Dieguez et al. In Utero Exposure to Maternal Hyperglycemia and Offspring Type 2 Diabetes Genetic Risk Score Are Independently Associated With Risk of Impaired Glucose Tolerance in Youth. Diabetes Care 2025;48:1356-1360.
    Diabetes Care. 2025;48:e117-e118.
    PubMed        
    
    
39. SATTAR N, Fruhbeck G, Andreelli F, Garcia-Perez LE, et al
    Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2.
    Diabetes Care. 2025 Aug 21:dc251442. doi: 10.2337/dc25-1442.
    PubMed        
    
    
40. HIRSCH IB, Eckel RH
    Cardiovascular Outcome Trials in Type 1 Diabetes: We Are Not There Yet.
    Diabetes Care. 2025;48:1481-1483.
    PubMed        
    
    
41. LEE MMY, McGuire DK, Sattar N
    Response to Comment on Lee et al. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without
    Diabetes Care. 2025;48:e109-e110.
    PubMed        
    
    
42. 
    Expression of Concern. Alam Khan, Mahpara Safdar, Mohammad Muzaffar Ali Khan, Khan Nawaz Khattak, and Richard A. Anderson. Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. Diabetes Care 2003;26:3215-3218. DOI: 10.2337/diacare.26.12
    Diabetes Care. 2025;48:1646.
    PubMed        
    
    
43. CHANG YT, Lo SC, Kornelius E
    Comment on Lee et al. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabe
    Diabetes Care. 2025;48:e107-e108.
    PubMed        
    
    
44. LUNDEMOSE SB, Ranjan AG, Norgaard O, Suvitaival T, et al
    Low-Dose Glucagon to Prevent and Treat Exercise-Associated Hypoglycemia in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2025;48:1637-1645.
    PubMed         Abstract available
    
    
45. HASEBE M, Su CY
    Comment on Dieguez et al. In Utero Exposure to Maternal Hyperglycemia and Offspring Type 2 Diabetes Genetic Risk Score Are Independently Associated With Risk of Impaired Glucose Tolerance in Youth. Diabetes Care 2025;48:1356-1360.
    Diabetes Care. 2025;48:e115-e116.
    PubMed        
    
    
46. BAGHERI S, Taylor SI
    Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-370.
    Diabetes Care. 2025;48:e111-e112.
    PubMed        
    
    
47. HAYNES A, Smith GJ, Tully A, Mellor BR, et al
    Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study.
    Diabetes Care. 2025 Aug 19:dc250821. doi: 10.2337/dc25-0821.
    PubMed         Abstract available
    
    
48. KUSINSKI LC, Atta N, Jones DL, Smith S, et al
    Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial.
    Diabetes Care. 2025 Aug 19:dc250452. doi: 10.2337/dc25-0452.
    PubMed         Abstract available
    
    
49. YANG J, Yin X, Tobias DK, Chen Z, et al
    Ultra-processed Foods and Diet Quality in Association With Long-term Weight Change and Progression to Type 2 Diabetes Among Individuals With a History of Gestational Diabetes Mellitus-A Prospective Study.
    Diabetes Care. 2025 Aug 18:dc250700. doi: 10.2337/dc25-0700.
    PubMed         Abstract available
    
    
50. TEMPLEMAN EL, Ferrat LA, Thomas N, Speake C, et al
    Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study.
    Diabetes Care. 2025;48:1571-1580.
    PubMed         Abstract available
    
    
51. MARI A, Stefanski A, van Raalte DH, Ma X, et al
    Tirzepatide Treatment and Associated Changes in beta-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.
    Diabetes Care. 2025 Jul 22:dc250763. doi: 10.2337/dc25-0763.
    PubMed         Abstract available
    
    
52. TURNER LV, Sherr JL, Zaharieva DP, Baran J, et al
    Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial.
    Diabetes Care. 2025;48:1598-1606.
    PubMed         Abstract available
    
    
53. ELDOR R, Avraham N, Rosenberg O, Shpigelman M, et al
    Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regime
    Diabetes Care. 2025;48:1607-1611.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

54. COSSU L, Facchinetti A, Bally L
    CGM profiling in Roux-en-Y gastric bypass, type 1 diabetes and healthy adults: Unmasking deviations from normoglycaemia.
    Diabetes Obes Metab. 2025 Aug 26. doi: 10.1111/dom.70059.
    PubMed        
    
    
55. AL-OZAIRI E, Al-Awadhi A, Mashankar A, Alroudhan D, et al
    Association of device-based measurement of physical activity with liver fat and stiffness in type 2 diabetes and obesity.
    Diabetes Obes Metab. 2025 Aug 26. doi: 10.1111/dom.70038.
    PubMed        
    
    
56. ANANDHAKRISHNAN A, Liarakos AL, Dhatariya K, Gallen G, et al
    Hybrid closed-loop systems in UK type 1 diabetes care: National survey of healthcare professional awareness, confidence, and training needs.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70027.
    PubMed         Abstract available
    
    
57. JI L, Yuan G, Liu J, Zhang B, et al
    Efficacy and safety of oral semaglutide in Chinese participants with type 2 diabetes: Subgroup analyses by baseline characteristics in the PIONEER 11 and 12 randomised controlled trials.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70031.
    PubMed         Abstract available
    
    
58. SARABHAI T, Kostev K
    SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70057.
    PubMed         Abstract available
    
    
59. CAI Z, Du M, Chen M, Ni G, et al
    An MRI study of pancreatic atrophy in children with type 1 diabetes: Heterogeneity, disease duration effects, and progression prediction models.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70055.
    PubMed         Abstract available
    
    
60. KANG S, Chen S, Lin Z, Zhang M, et al
    Association between Chinese visceral adiposity index and heart failure in diabetic patients.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70053.
    PubMed         Abstract available
    
    
61. LOGAN BK, Larsen R, Sacre JW, Cohen ND, et al
    Interrupting prolonged sitting reduces postprandial GIP but not GLP-1 responses in type 2 diabetes.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70046.
    PubMed        
    
    
62. SHEU WH, Lee CY, Wang YW, Liao CS, et al
    Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes.
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70023.
    PubMed         Abstract available
    
    
63. GAO L, Ji L, Yan X, Cheng Z, et al
    Efficacy and safety of chiglitazar add-on to metformin in type 2 diabetes mellitus (RECAM study).
    Diabetes Obes Metab. 2025 Aug 22. doi: 10.1111/dom.70009.
    PubMed         Abstract available
    
    
64. LIU Y, Wang Q
    Increased risk of type 1 diabetes in patients with autoimmune conditions-Further nuance needed.
    Diabetes Obes Metab. 2025 Aug 20. doi: 10.1111/dom.70041.
    PubMed        
    
    
65. LI X, Zhao W, Zhao L, Sun T, et al
    Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation.
    Diabetes Obes Metab. 2025 Aug 20. doi: 10.1111/dom.70043.
    PubMed         Abstract available
    
    
66. WU B, Nieman K, Sandoval R
    High-intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2025 Aug 18. doi: 10.1111/dom.70032.
    PubMed         Abstract available
    
    
67. TREVINO-ALVAREZ AM, Cabeza de Baca T, Stinson EJ, Gluck ME, et al
    Acidosis is associated with lower insulin sensitivity and incident type 2 diabetes in indigenous Americans: A prospective cohort study.
    Diabetes Obes Metab. 2025 Aug 18. doi: 10.1111/dom.70037.
    PubMed         Abstract available
    
    
68. WANG D, Morton JI, Magliano DJ, Shaw JE, et al
    Comparison of subcutaneous, visceral, liver and muscle fat depots in relation to prevalent and incident diabetes.
    Diabetes Obes Metab. 2025 Aug 18. doi: 10.1111/dom.70021.
    PubMed         Abstract available
    
    

    
    Diabetologia

69. 
    61(st) EASD Annual Meeting of the European Association for the Study of Diabetes : Vienna, Austria, 15 - 19 September 2025.
    Diabetologia. 2025 Aug 26. doi: 10.1007/s00125-025-06497.
    PubMed        
    
    
70. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Aug 21. doi: 10.1007/s00125-025-06520.
    PubMed         Abstract available
    
    
71. YU MG, Shah H, Jangolla S, Gauthier J, et al
    Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.
    Diabetologia. 2025 Aug 20. doi: 10.1007/s00125-025-06521.
    PubMed         Abstract available
    
    
72. SHI C, Wang X, Qin S, He A, et al
    BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06519.
    PubMed         Abstract available
    
    
73. HUHN EA, Kotzaeridi G, Fischer T, Todesco Bernasconi M, et al
    The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06517.
    PubMed         Abstract available
    
    
74. SPEKSNIJDER EM, Simsek S, Bisschop PH, Stenvers DJ, et al
    Perceived blood glucose regulation after menopause: a cross-sectional survey in women with type 1 diabetes in the Netherlands.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06518.
    PubMed         Abstract available
    
    
75. AUGUSTINE J, Troendle EP, Friedel T, Baldwin C, et al
    Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.
    Diabetologia. 2025 Aug 15. doi: 10.1007/s00125-025-06515.
    PubMed         Abstract available
    
    

    
    Eur J Endocrinol

76. LAVER TW, Patel KA
    MODY and Beyond: The Changing Face of Single-Gene Diabetes.
    Eur J Endocrinol. 2025 Aug 16:lvaf172. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

77. ZHANG Y, Wang R, Li Y, Zhu W, et al
    Hyperglycemia-Reduced Platelet-Derived Growth Factor-BB Expression Impairs Corneal Wound Healing in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2025;66:61.
    PubMed         Abstract available
    
    
78. HUBER KL, Steiner I, Pollreisz A
    Author Response: Retina Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2025;66:51.
    PubMed        
    
    
79. YANG Y, Zhang J
    Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:52.
    PubMed        
    
    
80. KAKIHARA S, Zhuang K, AbdelSalam M, Yamaguchi TC, et al
    The Importance of Matching Optical Coherence Tomography Angiography Metrics to Diabetic Retinopathy Severity for Detecting Progression.
    Invest Ophthalmol Vis Sci. 2025;66:49.
    PubMed         Abstract available
    
    
81. UNLU EK, Marx-Rattner R, Klein KA, Dawson VL, et al
    Differential Expression of the Synapse Regulatory Proteins Neurexins in Early Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2025;66:46.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

82. 
    Correction to: "The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study".
    J Clin Endocrinol Metab. 2025 Aug 26:dgaf471. doi: 10.1210.
    PubMed        
    
    
83. YOSHIJI S, Hasebe M, Tanaka D, Shimizu M, et al
    Genetic and Clinical Characteristics of Monogenic Diabetes in Japan: A Nationwide Study by the Japan Diabetes Society.
    J Clin Endocrinol Metab. 2025 Aug 25:dgaf478. doi: 10.1210.
    PubMed         Abstract available
    
    
84. BASU A
    Intensifying early diabetes education in youths with newly diagnosed type 1 diabetes for sustained glycemic outcomes.
    J Clin Endocrinol Metab. 2025 Aug 18:dgaf470. doi: 10.1210.
    PubMed        
    
    
85. MUIR CA, Wittert GA, Handelsman DJ
    Approach to the patient: Low testosterone concentrations in men with obesity.
    J Clin Endocrinol Metab. 2025 Mar 7:dgaf137. doi: 10.1210.
    PubMed         Abstract available
    
    
86. MOHAN S, Christie HE, Laurenti MC, Egan AM, et al
    Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance.
    J Clin Endocrinol Metab. 2025;110:e2956-e2965.
    PubMed         Abstract available
    
    

    
    J Clin Invest

87. KONG YX, Rehan R, Moreno CL, Madsen S, et al
    SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.
    J Clin Invest. 2025;135:e184597.
    PubMed         Abstract available
    
    
88. TAVARES-FERREIRA D, Shen BQ, Mwirigi JM, Shiers S, et al
    Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy.
    J Clin Invest. 2025 Aug 19:e184075. doi: 10.1172/JCI184075.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

89. KIM J, Bae S, Yun D, Park S, et al
    Clinical outcomes of and risk factors for normoalbuminuric diabetic kidney disease.
    J Diabetes Complications. 2025;39:109154.
    PubMed         Abstract available
    
    
90. WATANABE K, Nishioka H, Takubo M, Kosuda M, et al
    Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109150.
    PubMed         Abstract available
    
    
91. SCHMITTLING KA
    Risk assessment modeling for diabetes-related lower extremity amputation using socioeconomic and behavioral health indicators.
    J Diabetes Complications. 2025;39:109153.
    PubMed         Abstract available
    
    
92. CHEN KY, Chan HC, Chan CM
    Is there a link between dry eye disease and diabetes mellitus? A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109149.
    PubMed         Abstract available
    
    
93. TIAN J, Zhao C, Li Y, Han Y, et al
    The impact of glycemic variability on the 28-day prognosis of patients with cardiogenic shock with or without diabetes mellitus: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109151.
    PubMed         Abstract available
    
    

    
    Nature

94. KUEHL M, Okabayashi Y, Wong MN, Gernhold L, et al
    Pathology-oriented multiplexing enables integrative disease mapping.
    Nature. 2025;644:516-526.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

95. MOLANI-GOL R, Rafraf M, Safari S
    Effects of vitamin D supplementation on metabolic parameters, anthropometric measures, and diabetes risk in patients with prediabetes: an umbrella review of meta-analyses of randomized controlled trials.
    Nutr Metab (Lond). 2025;22:99.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

96. DING X, Xu J, Romano F, Garg I, et al
    Association of OCT Angiography-Detected Intraretinal Microvascular Abnormalities with Diabetic Retinopathy Severity.
    Ophthalmol Retina. 2025 Aug 19:S2468-6530(25)00369.
    PubMed         Abstract available
    
    

    
    Ophthalmology

97. YU CW, Nanji K, Garg A, Zaman M, et al
    The Prevalence of Diabetic Retinopathy in American Indians/Alaska Natives and non-Indigenous Americans: A Systematic Review and Meta-Analysis.
    Ophthalmology. 2025 Aug 13:S0161-6420(25)00513.
    PubMed         Abstract available
    
    

    
    PLoS One

98. KUANG SH, Chen TT, Ma WY, Chen ST, et al
    Is the pay-for-performance program associated with better quality of life among type 2 diabetes patients, including those with gastrointestinal conditions, in Taiwan? A cross-sectional survey.
    PLoS One. 2025;20:e0328910.
    PubMed         Abstract available
    
    
99. ALMEIDA JAB, Monteiro KS, Santino TA, Florencio RB, et al
    Assessment of the psychometric properties of self-management measurement instruments for individuals with type 2 diabetes: A systematic review protocol.
    PLoS One. 2025;20:e0330448.
    PubMed         Abstract available
    
    
100. AHMMED R, Islam MA, Hasan MT, Sarker A, et al
     Common molecular links and therapeutic insights between type 2 diabetes and kidney cancer.
     PLoS One. 2025;20:e0330619.
     PubMed         Abstract available
     
     
101. LIU Z, Qin Z, Bai W, Wang S, et al
     Integrating bioinformatics and machine learning to elucidate the role of protein glycosylation-related genes in the pathogenesis of diabetic kidney disease.
     PLoS One. 2025;20:e0329640.
     PubMed         Abstract available
     
     
102. KIM M, Park YG, Park YH
     Cataract surgery and the risk of developing recurrence or progression of diabetic macular edema.
     PLoS One. 2025;20:e0328874.
     PubMed         Abstract available
     
     
103. SONG J, Kang Y, Wang L, Guo Y, et al
     Effect of finerenone on urinary protein and inflammatory factor levels in type 2 diabetes mellitus patients with diabetic kidney disease.
     PLoS One. 2025;20:e0329965.
     PubMed         Abstract available
     
     

     
     Transplantation

104. YAKUBU I, Spengler J, Taylor P, LaPorte M, et al
     Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.
     Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005361.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.